Rocket, Labs

Rocket Lab's Two-Track Growth Story: Defense Windfalls, Japanese Repeat Orders, and the Neutron Question

Published on 08/08/2026 at 15:33 | Redaktion boerse-global.de

Rocket Lab wins $663M in US Space Force contracts, but heavy-lift Neutron remains unflown; Electron keeps steady launch cadence.

Rocket Lab Secures $663M Space Force Deals, Neutron Bets Big
Rocket Lab's Two-Track Growth Story: Defense Windfalls, Japanese Repeat Orders, and the Neutron Question Illustration mit AI erstellt übermittelt durch boerse-global.de

The numbers coming out of Rocket Lab these days are enough to make any space-sector investor do a double take. In the span of ten days, the company has locked in two major contracts from the US Space Force worth a combined $663 million. The stock responded with an 8.65 percent single-day jump on Friday, capping a week that saw the share price climb 26.95 percent. But strip away the headline figures, and a more layered picture emerges — one of a company straddling two very different realities: a proven, workhorse launch business and an ambitious, unproven heavy-lift future.

The Defense Pipeline Opens Wide

The larger of the two recent awards came on Tuesday, when the Space Force handed Rocket Lab a $397 million contract under the Space-Based Airborne Moving Target Indicator (SB-AMTI) program. The company will develop, launch, and operate a fleet of advanced "flatellite" spacecraft equipped with space-based sensors — all of which are slated to ride on the Neutron rocket, a vehicle that has yet to make its maiden flight. That detail is more than a footnote: it represents a significant bet by the military on a launcher that remains unproven in flight.

The second award, signed on July 27, was described by Rocket Lab as the largest launch contract in its corporate history. Valued at $266 million, it covers multiple suborbital missile-defense missions for the Space Force. Together, the two contracts — both originating from the defense budget — signal a broader shift: the US government increasingly turning to private players for capabilities once reserved for sprawling state-run programs. The SB-AMTI award is part of a larger $615 million Space Force package distributed among several providers for orbital tracking of airborne targets, with a third vendor remaining unnamed for confidentiality reasons.

Electron Keeps the Cadence

While Neutron and the Pentagon grab headlines, the smaller Electron rocket continues its quiet, reliable rhythm. On Thursday, Rocket Lab completed its 13th Electron launch of the year — the 92nd overall — delivering a satellite for Japanese customer iQPS. That mission followed a July 30 announcement in which iQPS booked three additional Electron flights, marking the third multi-launch order from the Japanese operator in under a year. With those additions, iQPS now has 18 Electron missions on the books for its planned 24-satellite constellation, seven of which have already flown. The new missions are scheduled to lift off from Rocket Lab's Launch Complex 1 starting in late 2027.

Should investors sell immediately? Or is it worth buying Rocket Lab?

NASA has also added to the pipeline. The agency selected Rocket Lab under a VADR contract capped at $300 million over ten years for two climate missions — PolSIR and TSIS-2 — which will measure tropical ice clouds and solar radiation, respectively. And in a display of rapid-response capability, the company launched the military's Victus Haze mission just 16 hours and 42 minutes after receiving the go-ahead, a new record that previously belonged to Firefly Aerospace.

This combination — steady, repeatable commercial orders alongside large, lumpy government contracts — is what sets Rocket Lab apart from pure Newspace speculation plays.

The Iridium Elephant

Looming over every individual contract is the proposed acquisition of Iridium Communications, announced on June 29. The deal values Iridium at roughly $8.0 billion, or $54 per share in a mix of cash and stock, with closing expected around mid-2027 pending shareholder and regulatory approvals. If completed, the transaction would transform Rocket Lab from a launch provider into an operator of its own satellite constellation — a fundamental shift in its business model. Whether Neutron flies on time and reliably will likely be a deciding factor in how credible that ambition ultimately proves.

Neutron: The Bottleneck and the Bet

The SB-AMTI win adds fresh urgency to Neutron's development timeline, since the contract cannot be fulfilled without the new rocket. Progress is being made: the Archimedes main engine has completed a test firing producing 1.5 million pounds of thrust, a figure comparable to SpaceX's Merlin 1D. The two-stage vehicle features a "Hungry Hippo" fairing system that remains attached to the rocket throughout the mission, opening and closing in seconds — the component has already arrived at the Wallops Island launch site. Neutron is designed to be reusable and capable of carrying up to 13,000 kilograms to orbit.

But the program has already slipped once, following a tank crack discovered during tests in January. Founder Peter Beck has been characteristically blunt: the rocket will launch when it's ready, not according to a fixed schedule. The company has also acquired robotics specialist Motiv Space Systems, a NASA Mars rover contributor, to bolster its satellite manufacturing capabilities.

A Stock Caught Between Enthusiasm and Caution

The market's reaction to the contract flurry has been characteristically volatile. At the German trading venue, shares closed Friday at €71.60, up 8.65 percent on the day. Over the past twelve months, the stock has gained 88.42 percent — yet it still sits roughly 46.49 percent below its 52-week high of €133.80. The 30-day annualized volatility stands at a striking 86.86 percent, a figure that speaks to the risk appetite of investors trading this growth story.

Rocket Lab at a turning point? This analysis reveals what investors need to know now.

Analyst sentiment remains broadly constructive. A consensus across several firms yields a moderate buy rating with a price target of $110.29, while KGI Securities rates the stock "Outperform" with a $107 target. Valuation models tell a more cautious story: a discounted cash flow analysis puts fair value at $81.92, suggesting the stock is already somewhat overvalued, with a price-to-earnings ratio of 21.9 against an industry average of 3.9. Free cash flow over the trailing twelve months stands at negative $300.8 million. Bulls point to a potential $800 billion market for space infrastructure; bears counter that the stock could be overvalued by as much as 410 percent.

Insider activity adds another layer of nuance. Over the past 90 days through early August, insiders sold Rocket Lab shares worth roughly $896 million, largely CEO Peter Beck through what appear to be pre-arranged selling programs. On July 8 alone, six insider sales totaling $82.1 million were recorded, and in early June, Alexander R. Slusky disposed of 40,000 shares at $123.60. Such sales often run through predetermined trading plans and don't necessarily reflect operational concerns — but they do coincide with a rally that has offered ample opportunity for profit-taking.

What Monday Will Tell

All eyes now turn to Monday, August 10, when Rocket Lab reports second-quarter 2026 earnings after the US market close. Analysts expect revenue of $231.6 million and a loss of 3 cents per share. Given the recent contract avalanche, the headline numbers may take a back seat to management's commentary on Neutron's timeline and the status of the Iridium acquisition. It's at that intersection — defense budgets, commercial constellations, and a rocket that has yet to prove itself in flight — where the question of whether Rocket Lab becomes an established systems provider or remains a high-flying Newspace story will ultimately be answered.

Ad

Rocket Lab Stock: New Analysis - 8 August

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 69928154 |